Laureate Pharma and Selexis SA, a Swiss-based contract developer of high performance production cell lines, will continue their collaboration via a joint marketing agreement. The collaboration will access complementary contract services in an effort to generate highly productive, stable mammalian cells producing gram quantities of recombinant protein materials in as few as eight weeks, post transfection. Additionally, the companies will simultaneously work to develop cGMP manufacturing proces...